ADASUVE 2-dose Thorough QT/QTc Study

Clinical trial NCT01854710 · COMPLETED

Trial details

NCT number: NCT01854710
Sponsor: Alexza Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2013-05-01
Primary completion: 2013-07-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.